![]() |
市场调查报告书
商品编码
1700090
脑电图设备市场预测至 2032 年:按产品类型、设备类型、应用、最终用户和地区进行的全球分析Electroencephalography Devices Market Forecasts to 2032 - Global Analysis By Product Type, Device Type, Application and End User and By Geography |
根据 Stratistics MRC 的数据,全球脑电图测量设备市场预计在 2025 年达到 15 亿美元,到 2032 年将达到 32 亿美元,预测期内的复合年增长率为 11.8%。
脑电图仪是医疗设备。它透过放置在头皮上的电极来检测脑电波模式,并有助于诊断癫痫、睡眠障碍和脑损伤等神经系统疾病。 EEG 设备范围从可携式到临床级,对于监测大脑功能和评估研究、神经病学和认知研究中的神经活动异常至关重要。
根据美国疾病管制与预防中心(CDC)的数据,到2022年,美国将有超过510万人患有癫痫病史,目前有340万人受到影响。
神经系统疾病盛行率不断上升
癫痫、阿兹海默症和帕金森氏症等神经系统疾病的盛行率不断上升,是脑电图设备需求的主要驱动因素。此外,老年人口的增加和对早期诊断的认识的提高也促进了市场的成长。此外,脑电图技术的进步使得非侵入性诊断更具吸引力,并成为监测脑部活动的首选方案。预计这一趋势将持续下去,有助于扩大市场。
开发中地区的准入受限
新兴市场对先进脑电图技术的取得有限阻碍了市场的成长。高成本和不足的医疗基础设施阻碍了这些地区的投资。此外,脑电图服务的限制性报销政策进一步限制了其采用。小型医院和诊所通常缺乏购买和维护复杂脑电图系统的资源,阻碍了其广泛应用。
人工智慧和机器学习集成
人工智慧和机器学习在脑电图分析中的整合代表着巨大的市场成长机会。这些技术将提高诊断准确性、提供预测洞察力并推动个人化医疗的创新。此外,人工智慧主导的脑电图系统可以自动解释资料,减少对专业知识的需求。此外,策略合作和研究资金对于利用这些机会和促进更复杂的 EEG 设备的开发至关重要。
与替代神经影像技术的竞争
EEG 机器面临来自 MRI、CT 和 PET 扫描等先进神经成像工具的竞争,这些工具为大脑结构评估提供了高空间解析度。儘管 EEG 具有良好的时间解析度并且具有成本效益,但单独使用它会带来挑战,因为在复杂情况下更倾向于使用多模式诊断。此外,增加对替代技术的研发投入可能会分散注意力,需要持续创新才能维持 EEG 系统的相关性。
COVID-19 疫情凸显了包括脑电图机在内的远端监控技术的重要性。然而,供应链中断和预算限制最初减缓了市场成长。随着经济復苏,对远端医疗和家庭监控解决方案的关注度不断提高,脑电图市场也因此受益。此外,疫情加速了数位健康技术的采用,为脑电图设备的长期成长奠定了基础。
医院和诊所部门预计在预测期内将实现最大幅度增长
由于患者数量多、基础设施先进、人力熟练,预计医院和诊所部门将在预测期内占据最大的市场占有率。在优惠报销政策的支持下,这些环境利用 EEG 进行关键诊断、手术监测和研究。此外,与学术机构合作进行临床试验增强了我们在该领域的领导地位。由于强大的医疗保健框架和神经系统疾病盛行率的上升,美国在医院脑电图应用方面处于领先地位。
穿戴式装置领域预计将在预测期内实现最高复合年增长率
受家庭监测和慢性病管理需求的推动,穿戴式装置领域预计将在预测期内实现最高成长率。轻巧的无线设计提高了患者的舒适度并实现了长期资料收集。此外,与智慧型手机和物联网平台的整合将支援即时分析,对消费者和临床医生都具有吸引力。专注于治疗癫痫和睡眠障碍的可穿戴设备的新兴企业正在推动创新,并为该行业的快速扩张做好准备。
在预测期内,北美预计将占据最大的市场占有率,这得益于其先进的医疗保健系统、高额的研发投入以及 Natus Medical 和 Cadwell Industries 等主要企业的强大影响力。神经系统疾病的高盛行率和保险覆盖率将进一步推动需求。此外,FDA 对人工智慧增强型脑电图设备的核准以及政府对脑研究的资助正在帮助该市场保持主导地位。
预计亚太地区在预测期内将呈现最高的复合年增长率,这得益于医疗保健服务的改善、人们对神经系统疾病的认识不断提高以及医疗旅游业的扩大。印度和中国等国家正在投资现代化诊断技术,而日本的人口老化也推动了需求。此外,与当地製造商以及提供具有成本效益的 EEG 系统的全球公司的合作正在加速市场渗透,使该地区成为高成长中心。
According to Stratistics MRC, the Global Electroencephalography Devices Market is accounted for $1.5 billion in 2025 and is expected to reach $3.2 billion by 2032 growing at a CAGR of 11.8% during the forecast period. Electroencephalography (EEG) devices are medical instruments used to measure and record electrical activity in the brain. They detect brain wave patterns through electrodes placed on the scalp, aiding in diagnosing neurological conditions like epilepsy, sleep disorders, and brain injuries. EEG devices range from portable to clinical-grade systems and are essential in research, neurology, and cognitive studies for monitoring brain function and assessing abnormalities in neural activity.
According to the Centers for Disease Control and Prevention (CDC), in 2022, over 5.1 million people in the U.S. had a history of epilepsy, with 3.4 million currently affected.
Increasing prevalence of neurological disorders
The rising incidence of neurological conditions such as epilepsy, Alzheimer's, and Parkinson's disease significantly drives the demand for EEG devices. Furthermore, the growing geriatric population and increased awareness about early diagnosis contribute to market growth. Additionally, advancements in EEG technology enhance its appeal for non-invasive diagnostics, making it a preferred choice for monitoring brain activity. This trend is expected to continue, bolstering the market's expansion.
Limited access in developing regions
Limited access to advanced EEG technology in developing regions hinders market growth. High costs and inadequate healthcare infrastructure discourage investments in these areas. Moreover, restricted reimbursement policies for EEG services further limit adoption. Smaller hospitals and clinics often lack the resources to purchase and maintain sophisticated EEG systems, creating barriers to widespread adoption.
Integration of Ai and machine learning
The integration of AI and machine learning in EEG analysis presents significant opportunities for market growth. These technologies enhance diagnostic accuracy and enable predictive insights, fostering innovation in personalized medicine. Furthermore, AI-driven EEG systems can automate data interpretation, reducing the need for specialized expertise. Additionally, strategic collaborations and research funding are crucial for capitalizing on these opportunities, driving the development of more sophisticated EEG devices.
Competition from alternative neuroimaging techniques
EEG devices face competition from advanced neuroimaging tools like MRI, CT, and PET scans, which offer higher spatial resolution for structural brain assessments. While EEG excels in temporal resolution and cost-effectiveness, preference for multi-modal diagnostics in complex cases challenges its standalone use. Additionally, rising R&D investments in alternative technologies may divert focus, necessitating continuous innovation in EEG systems to maintain relevance.
The COVID-19 pandemic highlighted the importance of remote monitoring technologies, including EEG devices. However, supply chain disruptions and budget constraints initially slowed market growth. As economies recover, the focus on telehealth and home-based monitoring solutions has increased, benefiting the EEG market. Furthermore, the pandemic accelerated the adoption of digital health technologies, positioning EEG devices for long-term growth.
The hospitals and clinics segment is expected to be the largest during the forecast period
The hospitals and clinics segment is expected to account for the largest market share during the forecast period, due to high patient footfall, advanced infrastructure, and skilled personnel. These settings utilize EEG for critical diagnoses, surgical monitoring, and research, supported by favorable reimbursement policies. Additionally, partnerships with academic institutions for clinical trials reinforce segment leadership. The U.S. led in hospital-based EEG adoption, driven by robust healthcare frameworks and rising neurological disorder prevalence.
The wearable devices segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the wearable devices segment is predicted to witness the highest growth rate, fueled by demand for home-based monitoring and chronic disease management. Lightweight, wireless designs enhance patient comfort, enabling long-term data collection. Moreover, integration with smartphones and IoT platforms supports real-time analytics, appealing to both consumers and clinicians. Startups focusing on epilepsy and sleep disorder wearables drive innovation, positioning this segment for rapid expansion.
During the forecast period, the North America region is expected to hold the largest market share, due to advanced healthcare systems, high R&D investments, and strong presence of key players like Natus Medical and Cadwell Industries. High neurological disorder prevalence and insurance coverage further propel demand. Additionally, FDA approvals for AI-enhanced EEG devices and government funding for brain research sustain market dominance.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by improving healthcare access, rising neurological disease awareness, and expanding medical tourism. Countries like India and China invest in modernizing diagnostics, while Japan's aging population boosts demand. Furthermore, local manufacturers offering cost-effective EEG systems and partnerships with global firms accelerate market penetration, positioning the region as a high-growth hub.
Key players in the market
Some of the key players in Electroencephalography Devices Market include Natus Medical Incorporated, Medtronic plc, Nihon Kohden Corporation, Cadwell Industries, Inc., NeuroWave Systems Inc., Electrical Geodesics, Inc. (EGI), Compumedics Limited, Koninklijke Philips N.V., GE Healthcare, Advanced Brain Monitoring, Inc., Brain Products GmbH, BioSemi, Emotiv, NeuroSky, g.tec medical engineering GmbH, ANT Neuro, Cephalon A/S and Noraxon U.S.A., Inc.
In January 2025, Brain Products released BrainVision Recorder 1.27.0001 and BrainVision Recorder for CGX 2.01.0102.
In January 2025, Emotiv, a global leader in EEG technology, announces its next-generation EEG Active Noise-Cancelling Earphones. These smart earphones enhance personal wellness by integrating advanced EEG technology to provide insights into cognitive performance and overall well-being-alongside exceptional sound quality.
In January 2024, Compumedics Limited is pleased to announce new MEG orders from Tsinghua and Tianjin Universities in China. These sales are via Compumedics' long-term Chinese distributor and partner, Beijing Fistar. The MEG systems, along with a host of peripherals including simultaneous EEG, stimulators, computers, and CURRY neuroimaging software, will ship to both sites in 2025. One order is for two single-helmet MEG systems, and the other is for a dual-helmet MEG system. Both will be configured for hyperscanning.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.